 | ||||||
| "anti diabetes" | ||||||
| NEWS | ||||||
| Jefferies reported on (NSE:FDC) First Data, bumping up its price target to $17 earlier today The Company's therapeutic segments include anti-infectives, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, ...
| ||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.